IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v16y2025i1d10.1038_s41467-025-63892-3.html
   My bibliography  Save this article

Non-canonical dihydrolipoyl transacetylase promotes chemotherapy resistance via mitochondrial tetrahydrofolate signaling

Author

Listed:
  • Jung Seok Hwang

    (Emory University School of Medicine)

  • JiHoon Kang

    (Emory University School of Medicine)

  • Jaehyun Kim

    (Emory University School of Medicine)

  • Kiyoung Eun

    (Emory University School of Medicine)

  • Sophia West

    (Emory University School of Medicine)

  • Hannah E. Bacho

    (Emory University School of Medicine)

  • Vanessa Avalos

    (Emory University School of Medicine)

  • Sydney Shuff

    (Emory University School of Medicine)

  • Dong M. Shin

    (Emory University School of Medicine)

  • Nabil F. Saba

    (Emory University School of Medicine)

  • Kelly R. Magliocca

    (Emory University School of Medicine)

  • Cheng-Kui Qu

    (Emory University School of Medicine)

  • Haian Fu

    (Emory University School of Medicine
    Emory University School of Medicine)

  • Suresh S. Ramalingam

    (Emory University School of Medicine)

  • Andrey A. Ivanov

    (Emory University School of Medicine)

  • Taro Hitosugi

    (Mayo Clinic)

  • Sumin Kang

    (Emory University School of Medicine)

Abstract

Chemotherapy is often a primary treatment for cancer. However, resistance leads to therapeutic failure. Acetylation dynamics play important regulatory roles in cancer cells, but the mechanisms by which acetylation mediates therapy resistance remain poorly understood. Here, using acetylome-focused RNA interference (RNAi) screening, we find that acetylation induced by mitochondrial dihydrolipoyl transacetylase (DLAT), independent of the pyruvate dehydrogenase complex, is pivotal in promoting resistance to chemotherapeutics, such as cisplatin. Mechanistically, DLAT acetylates methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) at lysine 44 and promotes 10-formyl-tetrahydrofolate (10-formyl-THF) and consequent mitochondrially encoded cytochrome c oxidase II (MT-CO2) induction. DLAT signaling is elevated in cancer patients refractory to chemotherapy or chemoimmunotherapy. A decoy peptide DMp39, designed to target DLAT signaling, effectively sensitizes cancer cells to cisplatin in patient-derived xenograft models. Collectively, our study reveals the crucial role of DLAT in shaping chemotherapy resistance, which involves an interplay between acetylation signaling and metabolic reprogramming, and offers a unique decoy peptide technology to overcome chemotherapy resistance.

Suggested Citation

  • Jung Seok Hwang & JiHoon Kang & Jaehyun Kim & Kiyoung Eun & Sophia West & Hannah E. Bacho & Vanessa Avalos & Sydney Shuff & Dong M. Shin & Nabil F. Saba & Kelly R. Magliocca & Cheng-Kui Qu & Haian Fu , 2025. "Non-canonical dihydrolipoyl transacetylase promotes chemotherapy resistance via mitochondrial tetrahydrofolate signaling," Nature Communications, Nature, vol. 16(1), pages 1-18, December.
    • Handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-63892-3
    DOI: 10.1038/s41467-025-63892-3
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-025-63892-3
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-025-63892-3?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-63892-3. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.